Loading
Latest filing published 08 May 2026 for HighTide Therapeutics, Inc. - B.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by MA Lixiong on record concern HighTide Therapeutics, Inc. - B, in the capacity of chief executive. Over a trading history stretching from 22 December 2023 to 30 April 2026, the count stands at 9 filings.
The open-market record consists of 1 sale, with no purchase. The totals exclude 1 filing filed without an amount. Since January 2026: no purchases and 1 sale on the market.
The record was last updated on 8 May 2026 with an open-market sale in HighTide Therapeutics, Inc. - B. Filings reach the HKEX feed a median of 8 days after the trade. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations